Andrea Ilari

20PUBLICATIONS
66CO-AUTHORS
Biomolecular modelling and designMedical devicesCheminformatics and quantitative structure-activity relationshipsNeurology and neuromuscular diseasesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 26, 2026
UbC4 from Leishmania is a Druggable E2 Ubiquitin Conjugating Enzyme: Structural Basis and Fragment Hits for Future E2-Recruiting PROTAC Development.

|Sep 18, 2026
Antileishmanial activity of gold(I) compounds containing triphenylphosphine ligands against Leishmania amazonensis: impacts on mitochondrial bioenergetics and trypanothione reductase activity.

|Sep 11, 2026
Second Generation of 2,2'-Di(indol-3-yl)ethanamines as Antileishmanial Agents: Phenotypic Hit Identification and Pharmacophore Studies.

|Apr 27, 2026
Iloperidone treatment mitigates the Juvenile Huntington's Disease phenotype possibly via Sigma-1 Receptor Modulation.

|Aug 29, 2024
Sorcin in Cancer Development and Chemotherapeutic Drug Resistance.

Cécile Exertier, Lorenzo Antonelli, Annarita Fiorillo

|Jan 02, 2024
Fragment Merging, Growing, and Linking Identify New Trypanothione Reductase Inhibitors for Leishmaniasis.

Cécile Exertier, Alessandra Salerno, Lorenzo Antonelli

Pageof 4

Frequent Collaborators

10 joint publications

Gianni Colotti

9 joint publications

Annarita Fiorillo

6 joint publications

Cécile Exertier

2 joint publications

Alessandra Salerno